VJHemOnc Podcast The role of BTK inhibitors in MCL, ongoing trials & future outlooks: updates from EHA 2024
Jul 22, 2024
Join experts Manali Kamdar, a leader at the University of Colorado Cancer Center, Tycel Phillips from City of Hope, and Chan Cheah of Linear Clinical Research as they dive into the transformative role of BTK inhibitors in treating mantle cell lymphoma. They discuss groundbreaking trial results, including the SHINE trial, and the significance of tumor profiling in guiding treatment for high-risk patients. The panel also explores the shift away from chemotherapy towards targeted therapies and the exciting future options such as CAR-T cells and bispecific antibodies.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 3min
Navigating BTK Inhibitors in Mantle Cell Lymphoma: Efficacy and Implications
02:35 • 2min
Evolving Strategies in Mantle Cell Lymphoma Treatment
04:45 • 2min
Advancements in BTK Inhibitor Therapy for Mantle Cell Lymphoma
06:17 • 3min
BTK Inhibitors and Treatment Advances in Mantle Cell Lymphoma
09:23 • 3min